APO Research, Inc.

APO RESEARCH · REPORT

Bonded Syringe

Selected research

Market Outlook & Growth Opportunities

Global Bonded Syringe Market Outlook and Growth Opportunities 2026

Market perspective

The global Bonded Syringe market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bonded Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bonded Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bonded Syringe is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bonded Syringe market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bonded Syringe market include BD, WEGO, Terumo, Medtronic, Vogt Medical, Smiths Medical, Retractable Technologies, Nipro Corporation and Henke Sass Wolf, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bonded Syringe market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bonded Syringe and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bonded Syringe sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bonded Syringe market size, projected growth trends, production technologies, key applications, and end-use industries.

Bonded Syringe Segment by Company

BD

WEGO

Terumo

Medtronic

Vogt Medical

Smiths Medical

Retractable Technologies

Nipro Corporation

Henke Sass Wolf

Gerresheimer AG

Bonded Syringe Segment by Type

PV 10-30 mL

PV Below 10 mL

PV Above 30 mL

Bonded Syringe Segment by Application

Hospital

Clinic

Bonded Syringe Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bonded Syringe status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bonded Syringe market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bonded Syringe significant trends, drivers, influence factors in global and regions.

6. To analyze Bonded Syringe competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bonded Syringe market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bonded Syringe and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bonded Syringe.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bonded Syringe market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bonded Syringe industry.

Chapter 3: Detailed analysis of Bonded Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bonded Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bonded Syringe in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bonded Syringe Industry Trends Table 2. Bonded Syringe Industry Drivers Table 3. Bonded Syringe Industry Opportunities and Challenges Table 4. Bonded Syringe Industry Restraints Table 5. Global Bonded Syringe Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bonded Syringe Revenue Share by Company (2021-2026) Table 7. Global Bonded Syringe Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Bonded Syringe Sales Volume Share by Company (2021-2026) Table 9. Global Bonded Syringe Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Bonded Syringe Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bonded Syringe Key Company Manufacturing Base & Headquarters Table 12. Global Bonded Syringe Company, Product Type & Application Table 13. Global Bonded Syringe Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bonded Syringe by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of PV 10-30 mL Table 18. Significant Companies of PV Below 10 mL Table 19. Significant Companies of PV Above 30 mL Table 20. Global Bonded Syringe Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Bonded Syringe Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Bonded Syringe Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Bonded Syringe Sales Volume Share by Type (2021-2026) Table 24. Global Bonded Syringe Sales Volume Share by Type (2027-2032) Table 25. Global Bonded Syringe Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bonded Syringe Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bonded Syringe Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bonded Syringe Sales Value Share by Type (2021-2026) Table 29. Global Bonded Syringe Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Global Bonded Syringe Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Bonded Syringe Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Bonded Syringe Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Bonded Syringe Sales Volume Share by Application (2021-2026) Table 36. Global Bonded Syringe Sales Volume Share by Application (2027-2032) Table 37. Global Bonded Syringe Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Bonded Syringe Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Bonded Syringe Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Bonded Syringe Sales Value Share by Application (2021-2026) Table 41. Global Bonded Syringe Sales Value Share by Application (2027-2032) Table 42. Global Bonded Syringe Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Bonded Syringe Sales by Region (2021-2026) & (K Units) Table 44. Global Bonded Syringe Sales Market Share by Region (2021-2026) Table 45. Global Bonded Syringe Sales by Region (2027-2032) & (K Units) Table 46. Global Bonded Syringe Sales Market Share by Region (2027-2032) Table 47. Global Bonded Syringe Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Bonded Syringe Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Bonded Syringe Sales Value Share by Region (2021-2026) Table 50. Global Bonded Syringe Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Bonded Syringe Sales Value Share by Region (2027-2032) Table 52. Global Bonded Syringe Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Bonded Syringe Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Bonded Syringe Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Bonded Syringe Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Bonded Syringe Sales by Country (2021-2026) & (K Units) Table 57. Global Bonded Syringe Sales Market Share by Country (2021-2026) Table 58. Global Bonded Syringe Sales by Country (2027-2032) & (K Units) Table 59. Global Bonded Syringe Sales Market Share by Country (2027-2032) Table 60. Global Bonded Syringe Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Bonded Syringe Sales Value Market Share by Country (2021-2026) Table 62. Global Bonded Syringe Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Bonded Syringe Sales Value Market Share by Country (2027-2032) Table 64. BD Company Information Table 65. BD Business Overview Table 66. BD Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. BD Bonded Syringe Product Portfolio Table 68. BD Recent Development Table 69. WEGO Company Information Table 70. WEGO Business Overview Table 71. WEGO Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. WEGO Bonded Syringe Product Portfolio Table 73. WEGO Recent Development Table 74. Terumo Company Information Table 75. Terumo Business Overview Table 76. Terumo Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Terumo Bonded Syringe Product Portfolio Table 78. Terumo Recent Development Table 79. Medtronic Company Information Table 80. Medtronic Business Overview Table 81. Medtronic Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Medtronic Bonded Syringe Product Portfolio Table 83. Medtronic Recent Development Table 84. Vogt Medical Company Information Table 85. Vogt Medical Business Overview Table 86. Vogt Medical Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Vogt Medical Bonded Syringe Product Portfolio Table 88. Vogt Medical Recent Development Table 89. Smiths Medical Company Information Table 90. Smiths Medical Business Overview Table 91. Smiths Medical Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Smiths Medical Bonded Syringe Product Portfolio Table 93. Smiths Medical Recent Development Table 94. Retractable Technologies Company Information Table 95. Retractable Technologies Business Overview Table 96. Retractable Technologies Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Retractable Technologies Bonded Syringe Product Portfolio Table 98. Retractable Technologies Recent Development Table 99. Nipro Corporation Company Information Table 100. Nipro Corporation Business Overview Table 101. Nipro Corporation Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Nipro Corporation Bonded Syringe Product Portfolio Table 103. Nipro Corporation Recent Development Table 104. Henke Sass Wolf Company Information Table 105. Henke Sass Wolf Business Overview Table 106. Henke Sass Wolf Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Henke Sass Wolf Bonded Syringe Product Portfolio Table 108. Henke Sass Wolf Recent Development Table 109. Gerresheimer AG Company Information Table 110. Gerresheimer AG Business Overview Table 111. Gerresheimer AG Bonded Syringe Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Gerresheimer AG Bonded Syringe Product Portfolio Table 113. Gerresheimer AG Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Bonded Syringe Distributors List Table 117. Bonded Syringe Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Bonded Syringe Product Image Figure 2. Global Bonded Syringe Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bonded Syringe Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bonded Syringe Sales (2021-2032) & (K Units) Figure 5. Global Bonded Syringe Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Bonded Syringe Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. PV 10-30 mL Image Figure 10. PV Below 10 mL Image Figure 11. PV Above 30 mL Image Figure 12. Global Bonded Syringe Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Bonded Syringe Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bonded Syringe Sales Volume Share by Type (2021-2032) Figure 15. Global Bonded Syringe Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bonded Syringe Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bonded Syringe Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Bonded Syringe Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Bonded Syringe Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Bonded Syringe Sales Volume Share by Application (2021-2032) Figure 23. Global Bonded Syringe Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Bonded Syringe Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Bonded Syringe Sales Value Share by Application (2021-2032) Figure 26. Global Bonded Syringe Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Bonded Syringe Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Bonded Syringe Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Bonded Syringe Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Bonded Syringe Sales Value (2021-2032) & (US$ Million) Figure 31. North America Bonded Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Bonded Syringe Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Bonded Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Bonded Syringe Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Bonded Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Bonded Syringe Sales Value (2021-2032) & (US$ Million) Figure 37. South America Bonded Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Bonded Syringe Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Bonded Syringe Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Bonded Syringe Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Bonded Syringe Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Bonded Syringe Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Bonded Syringe Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Bonded Syringe Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • PV 10-30 mL
  • PV Below 10 mL
  • PV Above 30 mL
Applications
  • Hospital
  • Clinic
Companies covered
  • BD
  • WEGO
  • Terumo
  • Medtronic
  • Vogt Medical
  • Smiths Medical
  • Retractable Technologies
  • Nipro Corporation
  • Henke Sass Wolf
  • Gerresheimer AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bonded Syringe Sales Value (2021-2032)
  4. 1.2.2 Global Bonded Syringe Sales Volume (2021-2032)
  5. 1.2.3 Global Bonded Syringe Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bonded Syringe Market Dynamics
  1. 2.1 Bonded Syringe Industry Trends
  2. 2.2 Bonded Syringe Industry Drivers
  3. 2.3 Bonded Syringe Industry Opportunities and Challenges
  4. 2.4 Bonded Syringe Industry Restraints
3 Bonded Syringe Market by Company
  1. 3.1 Global Bonded Syringe Company Revenue Ranking in 2025
  2. 3.2 Global Bonded Syringe Revenue by Company (2021-2026)
  3. 3.3 Global Bonded Syringe Sales Volume by Company (2021-2026)
  4. 3.4 Global Bonded Syringe Average Price by Company (2021-2026)
  5. 3.5 Global Bonded Syringe Company Ranking (2024-2026)
  6. 3.6 Global Bonded Syringe Company Manufacturing Base and Headquarters
  7. 3.7 Global Bonded Syringe Company Product Type and Application
  8. 3.8 Global Bonded Syringe Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bonded Syringe Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bonded Syringe Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bonded Syringe Market by Type
  1. 4.1 Bonded Syringe Type Introduction
  2. 4.1.1 PV 10-30 mL
  3. 4.1.2 PV Below 10 mL
  4. 4.1.3 PV Above 30 mL
  5. 4.2 Global Bonded Syringe Sales Volume by Type
  6. 4.2.1 Global Bonded Syringe Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bonded Syringe Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bonded Syringe Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bonded Syringe Sales Value by Type
  10. 4.3.1 Global Bonded Syringe Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bonded Syringe Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bonded Syringe Sales Value Share by Type (2021-2032)
5 Bonded Syringe Market by Application
  1. 5.1 Bonded Syringe Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Bonded Syringe Sales Volume by Application
  5. 5.2.1 Global Bonded Syringe Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Bonded Syringe Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Bonded Syringe Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Bonded Syringe Sales Value by Application
  9. 5.3.1 Global Bonded Syringe Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Bonded Syringe Sales Value by Application (2021-2032)
  11. 5.3.3 Global Bonded Syringe Sales Value Share by Application (2021-2032)
6 Bonded Syringe Regional Sales and Value Analysis
  1. 6.1 Global Bonded Syringe Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bonded Syringe Sales by Region (2021-2032)
  3. 6.2.1 Global Bonded Syringe Sales by Region: 2021-2026
  4. 6.2.2 Global Bonded Syringe Sales by Region (2027-2032)
  5. 6.3 Global Bonded Syringe Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bonded Syringe Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bonded Syringe Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bonded Syringe Sales Value by Region (2027-2032)
  9. 6.5 Global Bonded Syringe Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bonded Syringe Sales Value (2021-2032)
  12. 6.6.2 North America Bonded Syringe Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bonded Syringe Sales Value (2021-2032)
  15. 6.7.2 Europe Bonded Syringe Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bonded Syringe Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bonded Syringe Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bonded Syringe Sales Value (2021-2032)
  21. 6.9.2 South America Bonded Syringe Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bonded Syringe Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bonded Syringe Sales Value Share by Country, 2025 VS 2032
7 Bonded Syringe Country-level Sales and Value Analysis
  1. 7.1 Global Bonded Syringe Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bonded Syringe Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bonded Syringe Sales by Country (2021-2032)
  4. 7.3.1 Global Bonded Syringe Sales by Country (2021-2026)
  5. 7.3.2 Global Bonded Syringe Sales by Country (2027-2032)
  6. 7.4 Global Bonded Syringe Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bonded Syringe Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bonded Syringe Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bonded Syringe Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bonded Syringe Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bonded Syringe Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bonded Syringe Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bonded Syringe Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bonded Syringe Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bonded Syringe Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bonded Syringe Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bonded Syringe Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bonded Syringe Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bonded Syringe Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bonded Syringe Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bonded Syringe Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bonded Syringe Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bonded Syringe Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bonded Syringe Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bonded Syringe Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bonded Syringe Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bonded Syringe Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bonded Syringe Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bonded Syringe Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bonded Syringe Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bonded Syringe Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bonded Syringe Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bonded Syringe Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bonded Syringe Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bonded Syringe Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bonded Syringe Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bonded Syringe Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bonded Syringe Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bonded Syringe Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BD Bonded Syringe Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 WEGO
  8. 8.2.1 WEGO Company Information
  9. 8.2.2 WEGO Business Overview
  10. 8.2.3 WEGO Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 WEGO Bonded Syringe Product Portfolio
  12. 8.2.5 WEGO Recent Developments
  13. 8.3 Terumo
  14. 8.3.1 Terumo Company Information
  15. 8.3.2 Terumo Business Overview
  16. 8.3.3 Terumo Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Terumo Bonded Syringe Product Portfolio
  18. 8.3.5 Terumo Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Bonded Syringe Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 Vogt Medical
  26. 8.5.1 Vogt Medical Company Information
  27. 8.5.2 Vogt Medical Business Overview
  28. 8.5.3 Vogt Medical Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vogt Medical Bonded Syringe Product Portfolio
  30. 8.5.5 Vogt Medical Recent Developments
  31. 8.6 Smiths Medical
  32. 8.6.1 Smiths Medical Company Information
  33. 8.6.2 Smiths Medical Business Overview
  34. 8.6.3 Smiths Medical Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Smiths Medical Bonded Syringe Product Portfolio
  36. 8.6.5 Smiths Medical Recent Developments
  37. 8.7 Retractable Technologies
  38. 8.7.1 Retractable Technologies Company Information
  39. 8.7.2 Retractable Technologies Business Overview
  40. 8.7.3 Retractable Technologies Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Retractable Technologies Bonded Syringe Product Portfolio
  42. 8.7.5 Retractable Technologies Recent Developments
  43. 8.8 Nipro Corporation
  44. 8.8.1 Nipro Corporation Company Information
  45. 8.8.2 Nipro Corporation Business Overview
  46. 8.8.3 Nipro Corporation Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nipro Corporation Bonded Syringe Product Portfolio
  48. 8.8.5 Nipro Corporation Recent Developments
  49. 8.9 Henke Sass Wolf
  50. 8.9.1 Henke Sass Wolf Company Information
  51. 8.9.2 Henke Sass Wolf Business Overview
  52. 8.9.3 Henke Sass Wolf Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Henke Sass Wolf Bonded Syringe Product Portfolio
  54. 8.9.5 Henke Sass Wolf Recent Developments
  55. 8.10 Gerresheimer AG
  56. 8.10.1 Gerresheimer AG Company Information
  57. 8.10.2 Gerresheimer AG Business Overview
  58. 8.10.3 Gerresheimer AG Bonded Syringe Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Gerresheimer AG Bonded Syringe Product Portfolio
  60. 8.10.5 Gerresheimer AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bonded Syringe Value Chain Analysis
  2. 9.1.1 Bonded Syringe Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bonded Syringe Sales Mode & Process
  6. 9.2 Bonded Syringe Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bonded Syringe Distributors
  9. 9.2.3 Bonded Syringe Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.